Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
2.585 USD | -0.96% | +16.11% | +302.12% |
Nov. 17 | Office Properties Income Trust Appoints Yael Duffy as COO | MT |
Nov. 17 | Diversified Healthcare Trust Names Christopher Bilotto as New CEO | MT |
Financials (USD)
Sales 2023 * | 1.41B | Sales 2024 * | 1.49B | Capitalization | 628M |
---|---|---|---|---|---|
Net income 2023 * | -245M | Net income 2024 * | -197M | EV / Sales 2023 * | 0,45x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0,42x |
P/E ratio 2023 * | -2,51x | P/E ratio 2024 * | -3,28x | Employees | - |
Yield 2023 * | 1,53% | Yield 2024 * | 1,53% | Free-Float | 89.92% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +1.56% | ||
1 week | +23.70% | ||
Current month | +11.54% | ||
1 month | +6.53% | ||
3 months | +1.16% | ||
6 months | +50.00% | ||
Current year | +303.53% |
1 week
2.23
2.74

1 month
1.94
2.74

Current year
0.64
3.30

1 year
0.61
3.30

3 years
0.61
5.58

5 years
0.61
14.31

10 years
0.61
24.60

Managers | Title | Age | Since |
---|---|---|---|
Jennifer Francis
CEO | Chief Executive Officer | 59 | 2018 |
Michael Kodesch
IRC | Investor Relations Contact | - | - |
Vern D. Larkin
AUD | Comptroller/Controller/Auditor | 53 | 2012 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Portnoy
CHM | Chairman | 52 | 2006 |
Jeffrey Somers
BRD | Director/Board Member | 80 | 2009 |
Lisa Jones
BRD | Director/Board Member | 55 | 2015 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.60% | 5,840 M€ | +9.57% | ||
0.21% | 1,784 M€ | +8.93% | ||
0.18% | 512 M€ | +1.33% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-06 | 2.6 | -0.38% | 628 637 |
23-12-05 | 2.61 | +1.56% | 1,117,270 |
23-12-04 | 2.57 | -3.02% | 949,810 |
23-12-01 | 2.65 | +13.25% | 1,662,152 |
23-11-30 | 2.34 | +4.46% | 1,295,922 |
Delayed Quote Nasdaq, December 05, 2023 at 04:00 pm EST
More quotes
Diversified Healthcare Trust is a real estate investment trust (REIT). The Company owns medical office and life science properties, senior living communities, and other healthcare related properties throughout the United States. The Company's segments include Office Portfolio and SHOP. Its Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents where it pays fees to the operator to manage the communities for its account. The Company portfolio consists of constructed commercial properties to operate as medical office space for physicians and other healthcare personnel, medical related fields, including clinics and life science or laboratory.
Sector
Specialized REITs
Calendar
2024-02-28
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2.61USD
Average target price
4.5USD
Spread / Average Target
+72.41%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+303.53% | 628 M $ | |
+37.12% | 49 746 M $ | |
+4.20% | 18 875 M $ | |
-26.77% | 10 044 M $ | |
+10.91% | 7 595 M $ | |
-16.81% | 5 972 M $ | |
+16.01% | 3 334 M $ | |
-54.04% | 3 064 M $ | |
-18.87% | 3 133 M $ | |
-14.93% | 2 931 M $ |